Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 40.49M 34.9M 32.13M 30.17M 56.65M 3.83B 57.24M 380M 148M 1.87B 152M 149M 6.5B | P/E Ratio 2024 |
-0.35x | P/E Ratio 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 31.37M 27.03M 24.89M 23.37M 43.88M 2.97B 44.34M 294M 115M 1.45B 118M 115M 5.03B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
87.13% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 40.49M | ||
| -0.12% | -0.18% | -12.80% | -12.90% | 43.58B | ||
| -1.84% | +5.00% | +294.85% | +537.81% | 34.03B | ||
| +0.56% | -3.61% | +12.74% | -16.89% | 29.77B | ||
| -1.27% | -1.20% | +0.20% | +32.34% | 29.82B | ||
| -0.29% | +9.47% | +13.95% | +21.93% | 25.42B | ||
| +4.09% | +9.58% | - | - | 13.87B | ||
| -0.86% | -0.76% | +53.91% | +108.83% | 13.35B | ||
| -1.04% | -3.48% | +2.42% | +1.98% | 12.85B | ||
| -0.76% | -1.38% | +108.71% | +79.30% | 12.22B | ||
| Average | -0.92% | +2.03% | +59.24% | +94.05% | 23.88B | |
| Weighted average by Cap. | -0.37% | +2.02% | +61.15% | +105.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.4M 1.29M 1.21M 2.27M 154M 2.3M 15.23M 5.93M 75.18M 6.09M 5.96M 261M | 125K 108K 99.42K 93.35K 175K 11.85M 177K 1.17M 458K 5.8M 470K 460K 20.1M |
| Net income | -12.66M -10.91M -10.05M -9.44M -17.72M -1.2B -17.9M -119M -46.27M -586M -47.53M -46.52M -2.03B | -233M -201M -185M -174M -326M -22.04B -330M -2.19B -852M -10.79B -875M -856M -37.4B |
| Net Debt | 1.4M 1.2M 1.11M 1.04M 1.95M 132M 1.97M 13.09M 5.1M 64.65M 5.24M 5.13M 224M | -9.12M -7.86M -7.24M -6.8M -12.76M -863M -12.9M -85.57M -33.33M -422M -34.24M -33.52M -1.46B |
Employees
-

















